Nisoxetine

From WikiMD's WELLNESSPEDIA

Nisoxetine.svg

Selective norepinephrine reuptake inhibitor

Nisoxetine

Nisoxetine


IUPAC name (RS)-3-(2-Methoxyphenoxy)-3-phenylpropan-1-amine










CAS Number 62391-90-8
PubChem 4495


ChemSpider 4338
KEGG D05100




Nisoxetine is a selective norepinephrine reuptake inhibitor (NRI) that was initially developed as an antidepressant but was never marketed. It is primarily used in scientific research to study the role of norepinephrine in the central nervous system.

Pharmacology[edit]

Nisoxetine functions by inhibiting the reuptake of norepinephrine (NE) into presynaptic neurons, thereby increasing the concentration of NE in the synaptic cleft and enhancing its activity at postsynaptic receptors. This mechanism is similar to that of other NRIs such as atomoxetine and reboxetine.

Chemical Structure[edit]

The chemical structure of nisoxetine is characterized by a phenoxy group attached to a propanamine chain, with a methoxy group at the ortho position of the phenoxy ring. Its IUPAC name is (RS)-3-(2-Methoxyphenoxy)-3-phenylpropan-1-amine.

Research Applications[edit]

Nisoxetine is widely used in neuroscience research to investigate the effects of increased norepinephrine levels on various physiological and behavioral processes. Studies have utilized nisoxetine to explore its impact on mood disorders, attention-deficit hyperactivity disorder (ADHD), and pain management.

See Also[edit]

References[edit]



Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.